The ISHAGE guidelines for CD34+ cell determination by flow cytometry

Journal of Hematotherapy and Stem Cell Research

Volumn 5, Issue 3, 1996, Pages 213-226

  Sutherland, D Robert ^a,c   Anderson, Lori ^b   Keeney, Michael ^b   Nayar, Rakash ^a   Chin Yee, Ian ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c ISHAGE Stem Cell Enumeration C   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; MONOCLONAL ANTIBODY;

APHERESIS; CELL SEPARATION; CLINICAL LABORATORY; CLINICAL PROTOCOL; COLONY FORMING UNIT; FLOW CYTOMETRY; LEUKOCYTE COUNT; PERIPHERAL BLOOD STEM CELL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

ANTIGENS, CD34; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKOCYTE COUNT; PRACTICE GUIDELINES; STEM CELLS;

EID: 0029760436     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.213     Document Type: Review

References (46)

1. Civin, C., Trischman, T., Fackler, M.J., et al. Summary of CD34 cluster workshop section. In Leucocyte Typing IV, eds. Knapp, W., et al. Oxford University Press, Oxford, 1989, p. 818.
2. Sutherland, D.R. & Keating, A. The CD34 antigen: Structure, biology and potential clinical applications. J. Hematotherapy 1:115, 1992.
3. Berenson, R.J., Andrews, R.G., Bensinger, W.I., et al. Antigen CD34-positive marrow cells engraft lethally irradiated baboons. J. Clin. Invest. 81:951, 1988.
4. Shpall, E.J., Jones, R.B., Franklin, W., et al. Transplantation of autologous CD34+ hematopoietic progenitor cells into breast cancer patients following high-dosechemotherapy. J. Clin. Oncol. 12:28, 1994.
5. Andrews, R.G., Bryant, E.M., Bartelmez, S.H., et al. CD34+ marrow cells, devoid of T and B lymphocytes, reconstitute stable lymphopoiesis and myelopoiesis in lethally irradiated baboons: Blood 80:1693, 1992.
6. Juttner, C.A., To, L.B., Haylock, D.N., et al. Circulating autologous stem cells collected in very early remission from acute non-lymphoblastic leukemia produce prompt but incomplete hematopoietic reconstitution after high-dose melphalan or supralethal chemoradiotherapy. Br. J. Haematol. 61:739, 1985.
7. Siena, S., Bregni, M., Brando, B., et al. Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor. Blood 74:1905, 1989.
8. Kessinger, A. & Armitage, J.O. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 77:211, 1989.
9. Henon, P.R. Peripheral blood stem cell transplantation: Past present and future. Stem Cells 11:154, 1993.
10. Smith A. & Keating, A. Peripheral blood progenitor cell transplantation: Clinical, technical and economic considerations. J. Hematotherapy 3:331, 1994.
11. Chao, N.J., Schriber, J.R., Grimes, K., et al. Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapy. Blood 81:2031, 1993.
12. Brugger, W., Henschler, R., Heimfeld, S., et al. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 84:1421, 1994.
13. Freedman, A.S. & Nadler, L.M. Developments in purging in autotransplantation. Hematol. Oncol. Clin. North Am. 7:687, 1993.
14. Bregni, M., Magni, M., Siena, S., et al. Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood 80:1418, 1992.
15. Dunbar, C.E., Nienhuis, A.W., Stewart, F.M., et al. Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous leukemia, or metastatic breast cancer. Hum. Gene Ther. 4:205, 1993.
16. Wunder, E., Sovolat, H., Fritsch, G., et al. Report on the European workshop on peripheral blood stem cell determination and standardisation - Mulhouse, France. J. Hematotherapy 1:131, 1992.
17. Greaves, M.F., Titley, I., Colman, S.M., et al. Report on the CD34 cluster workshop. In Leukocyte Typing V, eds. Schlossman S., et al. 1995, p. 840.
18. Siena, S., Bregni, M., Belli, N., et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400, 1991.
19. Tricot, G., Jagannath, S., Vesole, D.H., et al. Peripheral blood stem cell transplants for multiple myeloma: Identification of favourable variables for rapid engraftment in 225 patients. Blood 85:588, 1995.
20. Bender, J.G., To, L.B., Williams, S., et al. Defining a therapeutic dose of peripheral blood stem cells. J. Hematotherapy 1:329, 1992.
21. Siena, S., Bregni, M., Di Nicola, M., et al. In Hematopoietic Stem Cells: The Mulhouse Manual, eds. Wunder, E., Sovolat, H., Henon, P.R. & Serke, S. Alphamed Press, Dayton, OH, 1994, p. 23.
22. Owens, M.A. & Loken, M.P. Peripheral blood stem cell quantitation. In Flow Cytometry Principles for Clinical Laboratory Practice. Wiley-Liss Inc., New York, 1995, p. 111.
23. Trischmann, T.M., Schepers, K.G. & Civin, C.I. Measurement of CD34+ cells in bone marrow by flow cytometry. J. Hematotherapy 2:305, 1993.
24. Kreissig, C., Kirsch, A. & Serke, S. Characterization and measurement of CD34-expressing hematopoietic cells. J. Hematotherapy 3:263, 1994.
25. Sutherland, D.R., Keating, A., Nayar, R., et al. Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry. Exp. Hematol. 22:1003, 1994.
26. Stewart, A.K., Imrie, K., Keating, A., et al. Optimizing the CD34+ Thy-1+ stem cell content of peripheral blood collections. Exp. Hematol. 23:1619, 1995.
27. Sutherland, D.R., Nayar, R., Stewart, A.K., et al. ISHAGE guidelines for the determination of CD34+ cells in whole blood using flow cytometry: Optimizing the timing of apheresis collection. In Hematopoietic Stem Cells: Methods Manual, eds. Wunder, E., Sovolat, H., Debecker, A., & Henon, P.R. Karger, Basel, 1996, vol. 2, in preparation.
28. Sutherland, D.R., Marsh, J.C.W., Davidson, J., et al. Differential sensitivity of CD34 epitopes to cleavage by Pasteurella haemolytica glycoprotease: Implications for purification of CD34-positive progenitor cells. Exp. Hematol. 20:590, 1992.
29. Sutherland, D.R., Yeo, E.L., Stewart, A.K., et al. Identification of CD34+ subsets following glycoprotease selection: Engraftment of CD34+/Thy-1+/Lin- stem cells in fetal sheep. Exp. Hematol. 24:795, 1996.
30. Lansdorp, P.M., Sutherland, H.J. & Eaves, C.J. Selective expression of CD45 isoforms on functional subpopulations of CD34+ hemopoietic cells from human bone marrow. J. Exp. Med. 172:363, 1990.
31. Shah, V.O., Civin, C.I. & Loken, M.R. Flow cytometric analysis of human bone marrow IV. Differential quantitative expression of T200 common leukocyte antigen during normal hemopoiesis. J. Immunol. 140:1861, 1988.
32. Stelzer, G.T., Shults, K.E. & Loken, M.R. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann. NY Acad. Sci. 677:265, 1993.
33. Borowitz, M.J., Guenther, K.L., Schults, K.E., et al. Immuno-phenotyping of acute leukemia by flow cytometry: Use of CD45 and right angle light scatter to gate on leukemic blasts in three color analysis. Am. J. Clin. Pathol. 100:534, 1993.
34. Streuli, M., Hall, L.R., Saga, Y., et al. Differential usage of three exons generates at least five different mRNAs encoding human leukocyte common antigens. J. Exp. Med. 166:1548, 1987.
35. Thomas, M.L. The leukocyte common antigen family. Annu. Rev. Immunol. 7:339, 1989.
36. Bender, J.G., Unverzagt, K.L., Walker, D.E., et al. Identification and comparison of CD34 positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 77:2591, 1991.
37. Murray, L., Chen, B., Galy, A., et al. Enrichment of hematopoietic stem cell activity in the CD34+Thy-1+Lin-subpopulation from mobilized peripheral blood. Blood 85:368, 1995.
38. Himmelfarb, J., Hakim, R.M., Holbrook, D.G., et al. Detection of granulocyte reactive oxygen species formation in whole blood using flow cytometry. Cytometry 13:83, 1992.
39. Chen, C.H., Lin, W., Shye, S., et al. Automated enumeration of CD34+ cells in peripheral blood and bone marrow. J. Hematotherapy 3:3, 1994.
40. Schmid, I., Krall, W.J., Uittenbógaart, C., et al. Dead cell discrimination with 7-actinomycin D in combination with dual color immunofluorescence in single-laser flow cytometry. Cytometry 13:204, 1992.
41. Koepke, S.A. & Landay, A.L. Precision and accuracy of absolute lymphocyte counts. Clin. Immunol. Immunopathol. 52:19, 1989.
42. Thompson, P.A., Grenier, K., Frey, T., et al. ProCOUNT™: A standardized system for CD34+ cell enumeration. In Hematopoietic Stem Cells: Methods Manual, eds. Wunder, E., Sovolat, H., Debecker, A., & Henon, P.R. Karger, Basel, 1996, vol. 2, in preparation.
43. Centers for Disease Control. 1995 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infection. MMWR 43 (No. RR-3):1, 1994.
44. Haas, R., Mohle, R., Pforsich, M., et al. Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells. Blood 85:1936, 1995.
45. Gazitt, Y., Tian, E., Barlogie, B., et al. Differential mobilization of myeloma cells and normal hematopoietic stem cells in multiple myeloma following treatment with cyclophosphamide and GM-CSF. Blood 87:805, 1996.
46. + hematopoietic stem cells. Blood 83:3758, 1994.